Business Wire

Velodyne Lidar Calls for Action to Improve Pedestrian Safety

Share

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today announced a white paper, written by Velodyne experts and published by SAE International, that calls for independent performance testing of driver assistance systems to be expanded to include dark, nighttime scenarios, as more than 75 percent of pedestrian fatalities occur in low-to-no light conditions. The change would address a gap in current testing protocols that primarily look at daytime conditions and largely overlook the risks to pedestrians from driver assistance systems which perform poorly in dark, nighttime conditions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210915005189/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Diagram of the Safety of the Intended Functionality (SOTIF) standard validation process, highlighting steps in the design, implementation and testing phases to ensure the safety function performance aligns with design intent. The SOTIF approach provides a methodology for identifying and maximizing the range of scenarios in which a vehicle can be expected to function safely under normal operation or with reasonably foreseeable misuse. (Graphic: Velodyne Lidar)

The white paper, called “Designing and assessing vehicle safety functions with a use case approach,” is available on the SAE International website. It can also be downloaded from the Velodyne website.

Recently, the National Highway Transportation Safety Administration (NHTSA) reported that motor vehicle traffic fatalities rose 10.5 percent in the first quarter of 2021 from the same time in 2020, with the vast majority of fatalities occurring in dark conditions. NHTSA also reports this staggering increase in deaths – an estimated 8,730 in three months – comes despite a decrease of 14.9 billion vehicle miles traveled during the same time. To address these tragedies, most new vehicles offer advanced driver assistance systems (ADAS), equipped with Pedestrian Automatic Emergency Braking (PAEB) as a standard optional feature.

Addressing PAEB Performance Limitations

PAEB systems are a foundational element for both AV and ADAS applications. They provide automatic braking for vehicles when pedestrians are in the path of the vehicle’s travel and the driver has taken insufficient action to avoid an imminent crash. However, current systems utilizing camera and radar technology frequently fail to protect pedestrians in dark conditions according to independent testing by the National Highway Traffic Safety Administration (NHTSA) and the American Automobile Association (AAA).

To reflect real-life conditions, the white paper proposes expanding future PAEB testing protocols to include tests conducted in dark, nighttime conditions. The new tests would be conducted in less than one lux ambient illuminance, using low-beam headlights and without streetlights. This change would provide the public with useful information on the performance of pedestrian detection systems in low-light conditions that occur on roadways.

To demonstrate how expanded testing would work, the white paper details the results of nighttime PAEB tests conducted by Velodyne. The tests evaluated a highly-rated PAEB system using current camera and radar-based technology and Velodyne’s PAEB system that uses Velodyne’s lidar sensors and Vella™ software. In these nighttime conditions, the camera and radar-based PAEB system failed in all five scenarios while the lidar-based system avoided a crash in every situation tested.

“PAEB systems can potentially have safety hazards related to nighttime driving and speed without system failure,” said Mircea Gradu, SVP of Automotive Programs, Velodyne Lidar. “Their performance can fall short under these real-world conditions due to limitations of sensors or software. Accurate situational awareness by ADAS and AVs is essential to safety.”

In March of 2021, the Governors Highway Safety Association reported a staggering 21 percent increase in the pedestrian fatality rate from 2019 to 2020. Additionally, on average, 100 lives are lost each day in motor vehicle crashes. While advanced driver assistance systems that perform in low- or no-light conditions have been available for years, they have yet to be wide adopted by automakers, even though they’ve proven to prevent crashes. Nearly four years ago, vehicles with mere front crash prevention technology had 64 percent fewer crashes with injuries than vehicles without it.

“With dark, nighttime conditions so dangerous for pedestrians, it is imperative vehicle assessment organizations expand PAEB testing in ambient light conditions of less than one lux,” said David Heeren, Director, Technology Research, Velodyne Lidar. “Tests performed by NHTSA and AAA demonstrate nighttime performance represents a major opportunity for improvement in current PAEB systems. Velodyne testing shows the efficacy of our lidar-based solution, which can strengthen a vehicle’s functional safety capabilities and address scenarios that cause thousands of pedestrian fatalities annually.”

About Velodyne Lidar

Velodyne Lidar (Nasdaq: VLDR, VLDRW) ushered in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne, the global leader in lidar, is known for its broad portfolio of breakthrough lidar technologies. Velodyne’s revolutionary sensor and software solutions provide flexibility, quality and performance to meet the needs of a wide range of industries, including autonomous vehicles, advanced driver assistance systems (ADAS), robotics, unmanned aerial vehicles (UAV), smart cities and security. Through continuous innovation, Velodyne strives to transform lives and communities by advancing safer mobility for all. For more information, visit www.velodynelidar.com.

Forward Looking Statements

This press release contains “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 including, without limitation, all statements other than historical fact and include, without limitation, statements regarding Velodyne’s target markets, new products, development efforts, and competition. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “can,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Velodyne’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include uncertainties regarding government regulation and adoption of lidar, the uncertain impact of the COVID-19 pandemic on Velodyne’s and its customers’ businesses; Velodyne’s ability to manage growth; Velodyne’s ability to execute its business plan; uncertainties related to the ability of Velodyne’s customers to commercialize their products and the ultimate market acceptance of these products; the rate and degree of market acceptance of Velodyne’s products; the success of other competing lidar and sensor-related products and services that exist or may become available; uncertainties related to Velodyne’s current litigation and potential litigation involving Velodyne or the validity or enforceability of Velodyne’s intellectual property; and general economic and market conditions impacting demand for Velodyne’s products and services. For more information about risks and uncertainties associated with Velodyne’s business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of Velodyne’s SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. All forward-looking statements in this press release are based on information available to Velodyne as of the date hereof, Velodyne undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Velodyne Investor Relations
InvestorRelations@velodyne.com

Velodyne Media
Codeword
Liv Allen
velodyne@codewordagency.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lone Star Acquires Multi-Asset Real Estate Portfolio from St. James’s Place17.11.2025 09:01:00 EET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VII, L.P. has successfully completed the acquisition of a multi-asset real estate portfolio from St. James’s Place (SJP) and its Property Unit Trust and Life and Pensions Trust. SJP was advised by Invesco Real Estate, the global real estate investment manager, on the sale of the portfolio. The portfolio comprises 16 high-quality assets across the UK, including multi-let industrial (“MLI”), retail, and office properties. The largest component is the MLI portfolio, which consists of 10 separate property assets predominantly located in Greater London and South East England, and offering access to major transportation and industrial hubs — making them highly attractive for last-mile delivery and regional distribution. The office properties are all situated in London, while the retail assets consist of high-quality retail warehouses with strong tenant bases. Lone Star will implement an active asset

Bureau Veritas appoints Santiago Arias Duval as Executive Vice-President for the Americas region17.11.2025 09:00:00 EET | Press release

Bureau Veritas, a global leader in Testing, Inspection and Certification (TIC), is pleased to announce the appointment of Santiago Arias Duval, effective November 17th, 2025, as Executive Vice-President, Americas. This appointment is in line with Bureau Veritas’ new operating model effective since September 1st, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251116192035/en/ Hinda Gharbi, CEO at Bureau Veritas Bureau Veritas is evolving the structure of its executive committee to drive greater organizational alignment. This organization will empower the regions with scalable Product Lines, enabling global solutions development, and will be unlocking wider cross-selling opportunities. The Americas region is created to leverage fast developing market opportunities across countries in North, Central and South America. This is a dynamic region for all Bureau Veritas where the group intends to expand its leadership across p

Incyte Announces Positive CHMP Opinion for Minjuvi ® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)17.11.2025 08:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Minjuvi® (tafasitamab) in combination with lenalidomide and rituximab for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) (Grade 1-3a) after at least one line of systemic therapy. "If approved, Minjuvi in combination with rituximab and lenalidomide will represent the first CD19- and CD20-dual-targeted immunotherapy for patients in Europe living with relapsed or refractory FL," said Lee Heeson, Executive Vice President and Head of Incyte International. "Based on the inMIND clinical trial results, Minjuvi has demonstrated its ability to offer patients improved progression free survival. The positive CHMP opinion is an encouraging step in our ongoing efforts to advance treatments that address critical gaps for patients." The positive CHMP opinion is based on

ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline17.11.2025 08:00:00 EET | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at the American Society for Dermatologic Surgery (ASDS) 2025 Annual Meeting, held in Chicago from November 13-16. Six poster presentations spotlighted the latest data on Restylane, Sculptra, and Relfydess*, while a series of onsite educational events through the Galderma Aesthetic Injector Network (GAIN) further showcased Galderma’s commitment to advancing aesthetic medicine through science-backed solutions. Spanning key treatment areas, the findings reinforce Galderma’s leadership in delivering meaningful outcomes and addressing unmet patient needs through robust clinical evidence and practitioner education. “From unveiling new data to educating practitioners and exploring emerging trends like facial volume loss associated with medication-driven weight loss, our presence at ASDS 2025 reflects Galderma’s holistic approach to a

UBS and Ant International Partner on Blockchain-Based Real-Time Cross-Border Payments Settlement and Liquidity Management17.11.2025 06:42:00 EET | Press release

UBS has entered a strategic partnership with Ant International, a leading global digital payment, digitisation, and financial technology provider, to explore innovations in blockchain-based tokenised deposits to support Ant International’s global payments settlement and liquidity management. Both parties signed a Memorandum of Understanding (MoU) at UBS’s flagship office at 9 Penang Road in Singapore. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251116743090/en/ From left to right: Young Jin Yee, Co-Head UBS Global Wealth Management Asia Pacific and Country Head Singapore, Kay Tin Khoo, Head Corporate Institutional Clients Asia Pacific, UBS, Kelvin Li, General Manager of Platform Tech at Ant International, and Douglas Feagin, President of Ant International at the MoU signing ceremony at UBS Singapore office at 9 Penang Road. Under the MoU, Ant International will leverage UBS Digital Cash, a blockchain-based payment platfor

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye